Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Subject to requirements
28 January, 2022
Clinical trial materials each have unique packaging requirements, and...
> read more

Choosing the right central lab 28 January, 2022 Central laboratories have become an important part of running global clinical trials in Europe and the US. With the rapid increase in the number of studies conducted in China and...

Rise to the challenge 28 January, 2022 Running a clinical trial can be a difficult process at the best of times, but the level of complexity can be orders of magnitude higher when it comes to rare disease research....

Clinical trials and tribulations 28 January, 2022 Even though they’re often a vital conduit between the drug and patient, ancillary supplies are sometimes seen as an afterthought for sponsors, who have been known to request items at...

Cash in on opportunity 28 January, 2022 Adaptive trial designs have enabled clinical research to keep up with Covid-19, but their operational costs and complexities might be harder to justify once the pandemic has passed...

Trial at home 28 January, 2022 Clinical trials have historically been done at hospitals or clinics, with subjects and researchers convening to get results. But with the rise of new technology – to say nothing of...

Next-gen vaccines 28 January, 2022 The lockdowns of 2020 and beyond led to economic disruption on a scale not seen outside of wartime, and the imperative to reduce some of this damage led to the fastest vaccines...

Reap the benefits 28 January, 2022 Clinical study protocols are important cornerstones on the journey of collecting the clinical data needed to elucidate the benefit-risk profile of medical treatments/devices....

The smart money 28 December, 2021 Smart packaging offers huge value to the whole of the supply chain. There are a number of recent innovations that can help optimise monitoring. Louise Thomas speaks to Ruud van der...

Counterfeit and proper 28 December, 2021 The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...

Waste not, want not 28 December, 2021 The health sector is responsible for an estimated 4.4% of global greenhouse gas emissions – the vast majority of which originate in the supply chain. One of the easiest ways to...

Mind the skills gap 10 November, 2021 There’s a skills shortage in the world of cell and gene therapy. This isn’t news; the problem has endured for years without a solution – but could that be because there isn’t one?...

Counterfeit and proper 10 November, 2021 The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...

Big issues, nano solutions 10 November, 2021 Proteins and peptides have come a long way since their medicinal potential was first realised, and yet oral delivery still faces age-old challenges. Andrew Tunnicliffe speaks...

Tech transfer: from bottleneck to boon 10 November, 2021 Outsourcing arrangements have been crucial to the roll-out of Covid-19 vaccines, and the pandemic has focused the industry’s gaze on the importance of broader collaboration,...

Hashgraphs for healthcare 10 November, 2021 Developing Covid-19 vaccines was a huge challenge, but successfully distributing them is another. Long-touted as revolutionary for pharma, distributed ledger technology has the...

The best shot 10 November, 2021 The validation of Covid-19 vaccines will go down in history as a turning point during this pandemic, but with highly specific storage and transportation requirements, the roll-outs...

Weighing the risks 10 November, 2021 Though vaccines are playing a huge role in the fight against Covid-19, some hesitancy remains. A few people have died from allergic reactions and blood clots likely sparked by the...

Chain reaction 10 November, 2021 Covid-19 has highlighted the need for pharmaceutical supply chains to be resilient and flexible. Building them to be agile and adaptive mitigates risk from sudden changes in supply...

Come together 27 July, 2021 Until relatively recently, patient engagement involved very few conversations with patients themselves. Good practice was anecdotal rather than the norm. Elly Earls talks to...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.